216 related articles for article (PubMed ID: 1721471)
1. Proliferating cell nuclear antigen expression in central nervous system neoplasms.
Allegranza A; Girlando S; Arrigoni GL; Veronese S; Mauri FA; Gambacorta M; Pollo B; Dalla Palma P; Barbareschi M
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):417-23. PubMed ID: 1721471
[TBL] [Abstract][Full Text] [Related]
2. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms.
Karamitopoulou E; Perentes E; Melachrinou M; Maraziotis T
Acta Neuropathol; 1993; 85(3):316-22. PubMed ID: 7681617
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
5. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
Korkolopoulou P; Oates J; Crocker J; Edwards C
J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
[TBL] [Abstract][Full Text] [Related]
6. Comparison of brain tumor growth kinetics by proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) labeling.
Lee KS; Yang WI
Yonsei Med J; 1992 Sep; 33(3):265-71. PubMed ID: 1363339
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of proliferative cells.
Mokrý J; Nĕmecek S
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers.
Tinnemans MM; Lenders MH; ten Velde GP; Wagenaar SS; Blijham GH; Ramaekers FC; Schutte B
Virchows Arch; 1995; 427(3):295-301. PubMed ID: 7496600
[TBL] [Abstract][Full Text] [Related]
9. PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.
Leonardi E; Girlando S; Serio G; Mauri FA; Perrone G; Scampini S; Dalla Palma P; Barbareschi M
J Clin Pathol; 1992 May; 45(5):416-9. PubMed ID: 1350788
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents.
Eldrige SR; Butterworth BE; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):211-8. PubMed ID: 7912188
[TBL] [Abstract][Full Text] [Related]
11. Immunostaining for proliferating cell nuclear antigen: its role in determination of proliferation in routinely processed human brain tumor specimens.
Khoshyomn S; Maier H; Morimura T; Kitz K; Budka H
Acta Neuropathol; 1993; 86(6):582-9. PubMed ID: 7906072
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study.
Louis DN; Edgerton S; Thor AD; Hedley-Whyte ET
Acta Neuropathol; 1991; 81(6):675-9. PubMed ID: 1679278
[TBL] [Abstract][Full Text] [Related]
13. Comparison of proliferating cell nuclear antigen to tritiated thymidine as a marker of proliferating hepatocytes in rats.
Foley J; Ton T; Maronpot R; Butterworth B; Goldsworthy TL
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):199-205. PubMed ID: 7912186
[TBL] [Abstract][Full Text] [Related]
14. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen expression in rat glioma model: comparison with bromodeoxyuridine labeling index.
Nakasu S; Nakajima M; Nioka H; Matsumura K; Handa J
Neurol Med Chir (Tokyo); 1994 May; 34(5):269-73. PubMed ID: 7519746
[TBL] [Abstract][Full Text] [Related]
16. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
17. Correlation between [3H]thymidine and proliferating cell nuclear antigen (PCNA)/cyclin indices in archival, formaldehyde-fixed human colorectal tissues.
Bleiberg H; Morret M; Galand P
Eur J Cancer; 1993; 29A(3):400-3. PubMed ID: 8104445
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of proliferating cell nuclear antigen, bromodeoxyuridine, and mitotic index in uveal melanoma.
Ghazvini S; Kroll S; Char DH; Frigillana H
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2762-7. PubMed ID: 7499099
[TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen (PCNA): expression in samples of human astrocytic gliomas.
Revesz T; Alsanjari N; Darling JL; Scaravilli F; Lane DP; Thomas DG
Neuropathol Appl Neurobiol; 1993 Apr; 19(2):152-8. PubMed ID: 8100356
[TBL] [Abstract][Full Text] [Related]
20. Histone mRNA in-situ hybridization in astrocytomas: a comparison with PCNA, MIB-1 and mitoses in paraffin-embedded material.
Rautiainen E; Haapasalo H; Sallinen P; Rantala I; Helen P; Helin H
Histopathology; 1998 Jan; 32(1):43-50. PubMed ID: 9522215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
